Abstract
We examined a 41-year-old female with a subacute Budd-Chiari Syndrome (BCS) before and after implantation of a transjugular intrahepatic portosystemic stent shunt (TIPSS) by means of digital electroencephalography (EEG). After TIPSS implantation hepatic decompression had been achieved and the liver function as well as the clinical status improved daily. Simultaneously, the digital EEG showed a decrease in the power of the theta band and an increase in the physiological alpha frequency band. The theta/alpha ratio decreased after TIPSS, despite an elevated arterial ammonia level. The patient had a well-preserved liver parenchyma before the occurrence of the BCS. After portal decompression by TIPSS, the liver function normalized and the liver resumed efficient synthesis and parts of its detoxification task. This regeneration capacity was documented by a rise in cholinesterase after TIPSS. After temporary substitution of albumin the serum albumin concentration returned to normal. Thus, some neurotoxic substances with high albumin-binding capacity may not be absorbed by the central nervous system (CNS). Furthermore, it appears likely that the length of time the brain is exposed to neurotoxic substances plays a role in the clinical and electroencephalographic changes. Compared to the conventional EEG the theta/alpha ratio reflected better metabolically conditioned electroencephalographic changes after TIPSS.
Similar content being viewed by others
Abbreviations
- BCS:
-
Budd-Chiari Syndrome
- PSE:
-
portal-systemic encephalopathy
- HE:
-
hepatic encephalopathy
- sPSE:
-
subclinical portal-systemic encephalopathy
- TIPSS:
-
transjugular intrahepatic portosystemic stent shunt
- EEG:
-
electroencephalography
- MDF:
-
mean dominant frequency
- Hz:
-
Hertz
- PC:
-
personal computer
- CNS:
-
central nervous system
References
Bahn, E., Nolte, W., Kurth, C., Ramadori, G., Ruther, E., and Wiltfang, J. (2002). Quantification of the electroencephalographic theta/alpha ratio for the assessment of portal-systemic encephalopathy following implantation of transjugular intrahepatic portosystemic stent shunt (TIPSS). Metab. Brain Dis. 17:19–28.
Blum, U., Rossle, M., Haag, K., Ochs, A., Blum, H.E., Hauenstein, K.H., Astinet, F., and Langer, M. (1995). Budd-Chiari Syndrome–-Technical, hemodynamic, and clinical-results of treatment with transjugular intrahepatic portosystemic shunt. Radiology 197:805–811.
Butterworth, R.F. (1996). The neurobiology of hepatic encephalopathy. Semin. Liver Dis. 16:235–244.
Dilawari, J.B., Bambery, P., Chawla, Y., Kaur, U., Bhusnurmath, S.R., Malhotra, H.S., Sood, G.K., Mitra, S.K., Khanna, S.K., and Walia, B.S. (1994). Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 73:21–36.
Ganger, D.R., Klapman, J.B., McDonald, V., Matalon, T.A., Kaur, S., Rosenblate, H., Kane, R., Saker, M., and Jensen, D.M. (1999). Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis–-Review of indications and problems. Am. J. Gastroenterol. 94:603–608.
Jalan, R., Gooday, R., O’Carroll, R.E., Redhead, D.N., Elton, R.A., and Hayes, P.C. (1995). A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J. Hepatol. 23:697–705.
Mitchell, M.C., Boitnott, J.K., Kaufman, S., Cameron, J.L., and Maddrey, W.C. (1982). Budd-Chiari syndrome: Etiology, diagnosis and management. Medicine (Baltimore) 61:199–218.
Nolte, W., Figulla, H.R., Ringe, B., Wiltfang, J., Munke, H., Hartmann, H., and Ramadori, G. (1997). Transjugular intrahepatic portosystemic stent shunt (TIPSS) in Budd-Chiari syndrome with portal vein thrombosis. Deutsche Medizinische Wochenschrift 122:116–121.
Ochs, A., Rossle, M., Haag, K., Hauenstein, K.H., Deibert, P., Siegerstetter, V., Huonker, M., Langer, M., and Blum, H.E. (1995). The Transjugular Intrahepatic Portosystemic Stent-Shunt Procedure for refractory ascites. N. Engl. J. Med. 332:1192–1197.
Orloff, M.J., Daily, P.O., Orloff, S.L., Girard, B., and Orloff, M.S. (2000). A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann. Surg. 232:340–352.
Parsons-Smith, B.G., Summerskill, W.H., Dawson, A.M., and Sherlock, S. (1957). The electrograph in liver disease. Lancet 2:867–871.
Perello, A., Garcia-Pagan, J.C., Gilabert, R., Suarez, Y., Moitinho, E., Cervantes, F., Reverter, J.C., Escorsell, A., Bosch, J., and Rodes, J. (2002). TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 35:132–139.
Quero, J.C., Hartmann, I.J.C., Meulstee, J., Hop, W.C.J., and Schalm, S.W. (1996). The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 24:556–560.
Quero, J.C., and Schalm, S.W. (1996). Subclinical hepatic encephalopathy. Semin. Liver Dis. 16:321–328.
Van der Rijt, C.C., and Schalm, S.W. (1991). Spectral Analysis in Hepatic Encephalopathy, CRC, Boca Raton, FL.
Van der Rijt, C.C.D., Schalm, S.W., Degroot, G.H., and Devlieger, M. (1984). Objective measurement of hepatic-encephalopathy by means of automated EEG analysis. Electroencephalogr. Clin. Neurophysiol. 57:423–426.
Weissenborn, K., Scholz, M., Hinrichs, H., Wiltfang, J., Schmidt, F.W., and Kunkel, H. (1990). Neurophysiological assessment of early hepatic-encephalopathy. Electroencephalogr. Clin. Neurophysiol. 75:289–295.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bahn, E., Wiltfang, J., Nolte, W. et al. Quantification of Changes in Electroencephalographic Power Spectra in a Patient with Budd-Chiari-Syndrome after Implantation of a Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS). Metab Brain Dis 20, 1–6 (2005). https://doi.org/10.1007/s11011-005-2471-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11011-005-2471-4